Aymen Elfiky
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 30
- Cancer Immunotherapy and Biomarkers 11
- Cancer Treatment and Pharmacology 5
-
- Prostate Cancer Treatment and Research 19
- Renal cell carcinoma treatment 6
- Co-authors
- Muhammad Wasif Saif (5 shared papers)Ronald R. Salem (1 shared paper)Kamal Jethwani (2 shared papers)Stephen Agboola (2 shared papers)Joseph C. Kvedar (2 shared papers)Woong Ju (1 shared paper)Mei Han (1 shared paper)Jiezhong Chen (1 shared paper)
- Journals
- Journal of Clinical Oncology (18 papers)Healthcare (2 papers)Clinical Colorectal Cancer (2 papers)Clinical Genitourinary Cancer (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Aymen Elfiky
50 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Oncology 537
- Cancer Research 242
- Pulmonary and Respiratory Medicine 464
- Health Informatics 10
- Genetics 73
Countries citing papers authored by Aymen Elfiky
This map shows the geographic impact of Aymen Elfiky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aymen Elfiky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aymen Elfiky more than expected).
Fields of papers citing papers by Aymen Elfiky
This network shows the impact of papers produced by Aymen Elfiky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aymen Elfiky. The network helps show where Aymen Elfiky may publish in the future.
Co-authors
The 25 scholars most cited alongside Aymen Elfiky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 176 | |
| 2 | 2015 | 105 | |
| 3 | 2013 | 101 | |
| 4 | 2011 | 83 | |
| 5 | 2016 | 77 | |
| 6 | 2015 | 73 | |
| 7 | 2012 | 62 | |
| 8 | 2016 | 60 | |
| 9 | 2014 | 54 | |
| 10 | 2016 | 45 | |
| 11 | 2014 | 41 | |
| 12 | 2011 | 41 | |
| 13 | 2018 | 39 | |
| 14 | 2009 | 31 | |
| 15 | 2014 | 30 | |
| 16 | 2014 | 28 | |
| 17 | 2024 | 22 | |
| 18 | 2014 | 20 | |
| 19 | 2006 | 20 | |
| 20 | Identifying and treating fluoropyrimidine-associated hand-and-foot syndrome in white and non-white patients. | 2007 | 17 |
About Aymen Elfiky
Aymen Elfiky is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (19 papers), Cancer Immunotherapy and Biomarkers (11 papers), Renal cell carcinoma treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Economic and Financial Impacts of Cancer (5 papers), Cancer, Lipids, and Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Oncology (537 citations), Cancer Research (242 citations), Pulmonary and Respiratory Medicine (464 citations), Health Informatics (10 citations) and Genetics (73 citations). Aymen Elfiky has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Muhammad Wasif Saif, Ronald R. Salem, Kamal Jethwani, Stephen Agboola, Joseph C. Kvedar, Woong Ju, Mei Han, Jiezhong Chen, Chen Chen and Toni K. Choueiri. Their work appears in journals such as Journal of Clinical Oncology, Healthcare, Clinical Colorectal Cancer, Clinical Genitourinary Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.